Brief Report: “Allergic Symptoms” in Children with Autism Spectrum Disorders. More than Meets the Eye?
- 6 January 2011
- journal article
- review article
- Published by Springer Nature in Journal of Autism and Developmental Disorders
- Vol. 41 (11) , 1579-1585
Abstract
Many children with Autism Spectrum Disorders (ASD) have either family and/or personal history of “allergic symptomatology”, often in the absence of positive skin or RAST tests. These symptoms may suggest mast cell activation by non-allergic triggers. Moreover, children with mastocytosis or mast cell activation syndrome (MCAS), a spectrum of rare diseases characterized by increased number of activated mast cells in many organs, appear to have ASD at a rate tenfold higher (1/10 children) than that of the general population (1/100 children). Mast cell activation by allergic, infectious, environmental and stress-related triggers, especially perinatally, would release pro-inflammatory and neurotoxic molecules. We speculate these could disrupt the gut–blood–brain barriers, thus contributing to brain inflammation and ASD pathogenesis. Increased mast cell responsiveness may define at least a subgroup of ASD subjects, who could benefit from inhibition of mast cell activation.Keywords
This publication has 83 references indexed in Scilit:
- AutismThe Lancet, 2009
- A genome-wide linkage and association scan reveals novel loci for autismNature, 2009
- Comparing cortisol, stress, and sensory sensitivity in children with autismAutism Research, 2009
- Elevated immune response in the brain of autistic patientsJournal of Neuroimmunology, 2009
- Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disordersBrain, Behavior, and Immunity, 2009
- Luteolin inhibits myelin basic protein‐induced human mast cell activation and mast cell‐dependent stimulation of Jurkat T cellsBritish Journal of Pharmacology, 2008
- Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomesJournal of Neuroimmunology, 2008
- Luteolin reduces IL-6 production in microglia by inhibiting JNK phosphorylation and activation of AP-1Proceedings of the National Academy of Sciences, 2008
- IL-9– and mast cell–mediated intestinal permeability predisposes to oral antigen hypersensitivityJournal of Experimental Medicine, 2008
- Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent processProceedings of the National Academy of Sciences, 2006